Independent valuation





Our financial analyses are based on the "Directives on the Independence of Financial Research" issued by the Swiss Bankers Association in January 2008.  





We safeguard our independent valuations by:

  • a straightforward, systematic and transparent valuation methodology across all companies
  • standardized clinical risk adjustments
  • detailed NPV (net present value) calculations
  • proprietary "7Ps" analysis
  • fundamental research based on publicly available sources and independent expert views
  • cash life and break-even analyses
  • no broker or (investment) banking relationships


This serves our long-standing reputation in life science research among investors and companies.


NOTICE: Employees of valuationLAB AG, and their immediate household, are expressly prohibited to own securities or serve as an Officier, Director or Advisory Board Member of any company in the valuationLAB research universe.